Stock listing
Curasight A/s
Selected listing: CUS · FWB · EUR · DE
Curasight A/s (Frankfurt:CUS), Health Technology. Latest release Jul 27, 2026: Curasight Announces protocol update for the Phase I uTREAT trial in Aggressive…
- Ticker
- Frankfurt:CUS
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- Frankfurt
- Currency
- EUR
Latest news from Curasight A/s
Curasight Announces protocol update for the Phase I uTREAT trial in Aggressive Brain Cancer (Glioblastoma)
July 27, 2026
Curasight A/S has successfully completed a directed issue of shares of approximately DKK 20 million
June 22, 2026
Curasight A/S announces its intention to carry out a directed issue of shares
June 22, 2026
Curasight Announces Preliminary Readout from its Phase 1 Clinical Trial with uTREAT[®] in Aggressive Brain Cancer (Glioblastoma)
June 8, 2026
Curasight: Major Shareholding Notification - share transfer and ownership restructuring – related party transaction
April 26, 2026